BHCM
RLAY icon

Brevan Howard Capital Management’s Relay Therapeutics RLAY Stock Holding History

Brevan Howard Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-61,629
Closed -$322K – 2213
2025
Q3 		$322K Buy
+61,629
New +$235K ﹤0.01% 1533
2025
Q2 		– Sell
-46,548
Closed -$122K – 1998
2025
Q1 		$122K Buy
+46,548
New +$182K ﹤0.01% 1039
2024
Q4 		– Sell
-26,330
Closed -$186K – 1386
2024
Q3 		$186K Sell
26,330
-5,396
-17% -$40.3K 0.01% 1006
2024
Q2 		$207K Buy
31,726
+6,618
+26% +$45.2K 0.01% 881
2024
Q1 		$208K Buy
+25,108
New +$245K 0.02% 791

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return